Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: Pharma M&A gives UK stocks a lift

Tue, 22nd Apr 2014 08:59

- FTSE 100 at highest since April 4th - Astra jumps on Pfizer takeover speculation- GSK announces massive three-part deal with NovartistechMARK 2,729.51 +1.85%FTSE 100 6,683.16 +0.87%FTSE 250 16,031.64 +0.78%Strong gains from heavyweight pharmaceutical groups gave UK markets a boost on Tuesday morning, as investors returned to their desks in a positive mood following the four-day Bank Holiday weekend.AstraZeneca was rising strongly on speculation that Pfizer could make a takeover approach for the company in the region of £60bn, representing the biggest deal in industry history and the largest foreign takeover of a UK business ever.Meanwhile, GlaxoSmithKline (GSK) jumped after announcing a massive three-part deal with Swiss pharmaceuticals peer Novartis, which will see shareholders receive a £4bn capital return. M&A activity surrounding US companies Eli Lilly and Allergan were also giving lifting sentiment across the sector.The FTSE 100 was trading 0.9% higher at 6,683 in early trading; it has not closed above this level since April 4th when it finished the session at 6,695.55."Should the hurdles 6,600 and 6,650 be beaten (now turned supportive for any backtrack) the likelihood is that we go on to test six-week highs of 6,700," said Mike van Dulken, Head of Research at Accendo Markets.However, he said to "keep an eye on the tense Ukraine situation as it has the potential to overshadow any corporate news, be it good or bad".Astra, GSK lead pharma stocks highAstraZeneca was trading as much as 8% higher this morning after The Sunday Times said Pfizer made a tentative $100bn approach for its British-Swedish rival. While AstraZeneca reportedly rejected the informal offer, Analyst Andrew Baum from Citigroup said he expected Pfizer to "push aggressively ahead with a second approach".Investors at GSK celebrated the company's announcement this morning that will see it and Novartis create a new Consumer Healthcare business and exchange certain assets in a three-part major transaction. The proposed deal "accelerates our strategy to generate sustainable, broadly sourced sales growth and improve long-term earnings", said GSK's Chief Executive Sir Andrew Witty.Others in the sector including Shire, Smith & Nephew, BTG and NMC Health were also making decent gains this morning, along with pharmaceutical and biotech investment trust Worldwide Healthcare.Heading the other way were resource stocks with Rio Tinto, Randgold, Shell, Glencore Xstrata and BG Group trading in the red.Even Polymetal was lower despite the Russian precious metals producer saying it had made a "strong start to the year" with 34% growth in production. Sales, however, lagged output during the period due to seasonal factors.FTSE 250-listed telecoms provider Colt was a heavy faller this morning after saying margin pressures chipped away at quarterly earnings. The company warned that full-year operating profit before restructuring charges is expected to range between 5% and 10% below current consensus estimates.FTSE 100 - RisersAstraZeneca (AZN) 4,072.50p +7.70%Shire Plc (SHP) 3,054.00p +4.41%GlaxoSmithKline (GSK) 1,625.50p +4.27%Royal Mail (RMG) 523.00p +2.75%Diageo (DGE) 1,865.50p +2.00%Smith & Nephew (SN.) 882.00p +1.85%Aberdeen Asset (ADN) 444.80p +1.83%British Sky Broadcasting Group (BSY) 904.50p +1.63%Melrose Industries (MRO) 286.00p +1.49%GKN (GKN) 396.70p +1.46%FTSE 100 - FallersRandgold Resources Ltd. (RRS) 4,631.00p -1.84%Rio Tinto (RIO) 3,250.50p -1.16%Babcock International Group (BAB) 1,206.00p -0.82%Anglo American (AAL) 1,535.00p -0.78%Glencore Xstrata (GLEN) 312.45p -0.54%Standard Chartered (STAN) 1,321.50p -0.30%Fresnillo (FRES) 865.50p -0.29%RSA Insurance Group (RSA) 94.55p -0.16%BAE Systems (BA.) 388.60p -0.13%Petrofac Ltd. (PFC) 1,403.00p -0.07%FTSE 250 - RisersBTG (BTG) 551.00p +4.06%Worldwide Healthcare Trust (WWH) 1,255.00p +3.29%NMC Health (NMC) 514.00p +2.99%Go-Ahead Group (GOG) 2,044.00p +2.77%Phoenix Group Holdings (DI) (PHNX) 654.00p +2.19%Genus (GNS) 1,020.00p +2.10%Enterprise Inns (ETI) 142.90p +2.07%Hikma Pharmaceuticals (HIK) 1,527.00p +2.07%Rank Group (RNK) 161.60p +2.02%Murray Income Trust (MUT) 775.50p +1.97%FTSE 250 - FallersCOLT Group SA (COLT) 131.20p -9.33%Centamin (DI) (CEY) 52.75p -1.86%Computacenter (CCC) 643.50p -1.00%African Barrick Gold (ABG) 257.00p -0.81%PayPoint (PAY) 1,171.00p -0.76%Wetherspoon (J.D.) (JDW) 848.00p -0.64%EnQuest (ENQ) 127.80p -0.62%Kazakhmys (KAZ) 232.60p -0.60%QinetiQ Group (QQ.) 220.60p -0.45%Polymetal International (POLY) 611.00p -0.41%BC
More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.